Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201 Article

Chi, Andrew S, Tarapore, Rohinton S, Hall, Matthew D et al. (2019). Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201 . JOURNAL OF NEURO-ONCOLOGY, 145(1), 97-105. 10.1007/s11060-019-03271-3

Open Access

cited authors

  • Chi, Andrew S; Tarapore, Rohinton S; Hall, Matthew D; Shonka, Nicole; Gardner, Sharon; Umemura, Yoshie; Sumrall, Ashley; Khatib, Ziad; Mueller, Sabine; Kline, Cassie; Zaky, Wafik; Khatua, Soumen; Weathers, Shiao-Pei; Odia, Yazmin; Niazi, Toba N; Daghistani, Doured; Cherrick, Irene; Korones, David; Karajannis, Matthias A; Kong, Xiao-Tang; Minturn, Jane; Waanders, Angela; Arillaga-Romany, Isabel; Batchelor, Tracy; Wen, Patrick Y; Merdinger, Krystal; Schalop, Lee; Stogniew, Martin; Allen, Joshua E; Oster, Wolfgang; Mehta, Minesh P

sustainable development goals

authors

publication date

  • October 1, 2019

published in

keywords

  • Adult
  • Clinical Neurology
  • DRD2 antagonist
  • Diffuse intrinsic pontine
  • Diffuse midline
  • Glioma
  • H3 K27M
  • Life Sciences & Biomedicine
  • MUTATION
  • Neurosciences & Neurology
  • ONC201
  • Oncology
  • Pediatric
  • Radiation
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • SPRINGER

start page

  • 97

end page

  • 105

volume

  • 145

issue

  • 1